Russell Investments Group, Ltd. Kinnate Biopharma Inc. Transaction History

Russell Investments Group, Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$2.33 - $6.84 $1,470 - $4,316	631 New	631 $1,000
Q3 2022 Nov 04, 2022	BUY	$9.86 - $15.76 $9,416 - $15,050	955 New	955 $11,000
Q1 2022 May 05, 2022	SELL	$7.73 - $17.99 $429,540 - $999,668	-55,568 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$16.5 - $25.48 $546,364 - $843,719	33,113 Added 147.46%	55,568 $984,000
Q3 2021 Nov 08, 2021	BUY	$17.81 - $24.87 $399,923 - $558,455	22,455 New	22,455 $516,000

292K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.